Dubai Investments, a UAE-based multi-asset investment group managing a diverse portfolio of businesses, is showcasing the breadth of its manufacturing operations across pharmaceutical, glass, aluminium and steel structures at the ongoing Make it in the Emirates 2026 (Miite) event in Abu Dhabi.
Ashmore Investment Saudi Arabia, has signed the first investment under its Industrial Initiative, with the acquisition of a minority stake through a primary capital increase in Pharco KSA, the Saudi subsidiary of Pharco Pharmaceuticals.
Globalpharma, a wholly owned subsidiary of Dubai Investments and one of the UAE’s leading pharmaceutical manufacturers, has signed a strategic distribution agreement with United Medical Supplies (UNIMED), a key healthcare distributor under the Mohamed & Obaid Al Mulla Group.
Emirates Drug Establishment and Mubadala Bio Limited have signed a memorandum of understanding (MoU) to strengthen and advance the UAE’s medical products manufacturing sector as well as supporting national efforts to enhance pharmaceutical security and localise vital drug industries.
Eli Lilly and Company today announced it is building the most powerful supercomputer owned and operated by a pharmaceutical company, in collaboration with NVIDIA.
NVIDIA and Eli Lilly and Company on Thursday announced a first-of-its-kind AI co-innovation lab focused on applying AI to tackle some of the most enduring challenges in the pharmaceutical industry.
